Beam Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Beam Wealth Advisors's BMY Position: Q3 2025 in Review
Beam Wealth Advisors sold out of Bristol-Myers Squibb (BMY) in Q3 2025, closing a stake of 11,892 shares — an estimated $550K sold.
Beam Wealth Advisors first reported a position in BMY in Q2 2024 and held it in 5 quarters. The position peaked at $742K in Q1 2025. 2,274 funds tracked by Wall St. Rank hold BMY as of Q3 2025.
- Beam Wealth Advisors reported no remaining Bristol-Myers Squibb position as of Q3 2025 after selling out during the quarter.
- Beam Wealth Advisors sold 11,892 Bristol-Myers Squibb shares in Q3 2025, an estimated $550K.
- Beam Wealth Advisors first reported a position in Bristol-Myers Squibb in Q2 2024 and held it in 5 quarters.
- Beam Wealth Advisors's Bristol-Myers Squibb position peaked at $742K in Q1 2025.
- 2,274 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.
Based on Beam Wealth Advisors's 13F filing for Q3 2025, filed 5 Nov 2025.